KLK3 and pachyonychia congenita: Although the D'Amico risk assessment protocol included prostate-specific antigen and Gleason score compared with the TNM stage, it still ignores the impact of age, ethnicity, marriage, surgical style, and chemoradiotherapy on the survival of PC patients.